457 related articles for article (PubMed ID: 32234403)
1. The role of complement activation in autoimmune liver disease.
Biewenga M; Farina Sarasqueta A; Tushuizen ME; de Jonge-Muller ESM; van Hoek B; Trouw LA
Autoimmun Rev; 2020 Jun; 19(6):102534. PubMed ID: 32234403
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune hepatitis and overlap syndromes.
Dienes HP; Erberich H; Dries V; Schirmacher P; Lohse A
Clin Liver Dis; 2002 May; 6(2):349-62, vi. PubMed ID: 12122860
[TBL] [Abstract][Full Text] [Related]
4. High frequency of autoantibodies in patients with primary sclerosing cholangitis that bind biliary epithelial cells and induce expression of CD44 and production of interleukin 6.
Xu B; Broome U; Ericzon BG; Sumitran-Holgersson S
Gut; 2002 Jul; 51(1):120-7. PubMed ID: 12077104
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of autoantibodies to p53 protein in patients with autoimmune liver diseases.
Himoto T; Yoneyama H; Kurokohchi K; Inukai M; Masugata H; Goda F; Haba R; Watanabe S; Senda S; Masaki T
Can J Gastroenterol; 2012 Mar; 26(3):125-9. PubMed ID: 22408762
[TBL] [Abstract][Full Text] [Related]
6. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
7. Elevation of gamma delta T lymphocytes in peripheral blood and livers of patients with primary sclerosing cholangitis and other autoimmune liver diseases.
Martins EB; Graham AK; Chapman RW; Fleming KA
Hepatology; 1996 May; 23(5):988-93. PubMed ID: 8621180
[TBL] [Abstract][Full Text] [Related]
8. Overlap syndrome: autoimmune hepatitis with primary biliary cirrhosis.
Arulprakash S; Sasi AD; Bala MR; Pugazhendhi T; Kumar SJ
J Assoc Physicians India; 2010 Jul; 58():455-6. PubMed ID: 21121216
[TBL] [Abstract][Full Text] [Related]
9. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
10. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
Koyabu M; Uchida K; Miyoshi H; Sakaguchi Y; Fukui T; Ikeda H; Takaoka M; Hirohara J; Nishio A; Uemura Y; Uemoto S; Okazaki K
J Gastroenterol; 2010 Jul; 45(7):732-41. PubMed ID: 20087609
[TBL] [Abstract][Full Text] [Related]
11. Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population.
Boberg KM; Aadland E; Jahnsen J; Raknerud N; Stiris M; Bell H
Scand J Gastroenterol; 1998 Jan; 33(1):99-103. PubMed ID: 9489916
[TBL] [Abstract][Full Text] [Related]
12. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive assessment of ECM turnover using serum biomarkers establishes PBC as a high-turnover autoimmune liver disease.
Vesterhus M; Nielsen MJ; Hov JR; Saffioti F; Manon-Jensen T; Leeming DJ; Moum B; Boberg KM; Pinzani M; Karlsen TH; Karsdal MA; Thorburn D
JHEP Rep; 2021 Feb; 3(1):100178. PubMed ID: 33225252
[TBL] [Abstract][Full Text] [Related]
14. A spectrum of histopathologic findings in autoimmune liver disease.
Terracciano LM; Patzina RA; Lehmann FS; Tornillo L; Cathomas G; Mhawech P; Vecchione R; Bianchi L
Am J Clin Pathol; 2000 Nov; 114(5):705-11. PubMed ID: 11068543
[TBL] [Abstract][Full Text] [Related]
15. Trends in Incidence of Autoimmune Liver Diseases and Increasing Incidence of Autoimmune Hepatitis.
Lamba M; Ngu JH; Stedman CAM
Clin Gastroenterol Hepatol; 2021 Mar; 19(3):573-579.e1. PubMed ID: 32526342
[TBL] [Abstract][Full Text] [Related]
16. Autoimmune liver disease: overlap and outliers.
Washington MK
Mod Pathol; 2007 Feb; 20 Suppl 1():S15-30. PubMed ID: 17486048
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of autoimmune liver disease.
Feld JJ; Heathcote EJ
J Gastroenterol Hepatol; 2003 Oct; 18(10):1118-28. PubMed ID: 12974897
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
19. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of autoimmune liver disease natural history in patients referred to Middle East Liver Diseases (MELD) center.
Nejad SEM; Heiat M; Javanbakht M; Alavian SM; Haris MAA
BMC Gastroenterol; 2024 Jan; 24(1):17. PubMed ID: 38178070
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
